China Regenerative Medicine International Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 282.9 million compared to HKD 185.34 million a year ago. Net income was HKD 13.35 million compared to net loss of HKD 404.23 million a year ago.

Basic earnings per share from continuing operations was HKD 0.02. Diluted earnings per share from continuing operations was HKD 0.02. Basic earnings per share was HKD 0.01.

Diluted earnings per share was HKD 0.01.